Pages that link to "Q30457808"
Jump to navigation
Jump to search
The following pages link to Adenosine hypothesis of schizophrenia--opportunities for pharmacotherapy (Q30457808):
Displaying 50 items.
- The Biochemistry and Epigenetics of Epilepsy: Focus on Adenosine and Glycine (Q26752724) (← links)
- Adenosine kinase: exploitation for therapeutic gain (Q26852056) (← links)
- Mice lacking the circadian modulators SHARP1 and SHARP2 display altered sleep and mixed state endophenotypes of psychiatric disorders (Q27335150) (← links)
- Neurochemical measurement of adenosine in discrete brain regions of five strains of inbred mice (Q28541087) (← links)
- Adenosine Kinase Deficiency in the Brain Results in Maladaptive Synaptic Plasticity. (Q30355611) (← links)
- Dipyridamole monotherapy in schizophrenia: pilot of a novel treatment approach by modulation of purinergic signaling (Q30438924) (← links)
- Deletion of striatal adenosine A(2A) receptor spares latent inhibition and prepulse inhibition but impairs active avoidance learning (Q30440698) (← links)
- Upregulation of adenosine A2A receptors induced by atypical antipsychotics and its correlation with sensory gating in schizophrenia patients (Q30445339) (← links)
- Adenosine augmentation ameliorates psychotic and cognitive endophenotypes of schizophrenia. (Q30466024) (← links)
- The role of P2X7 receptors in a rodent PCP-induced schizophrenia model (Q30827880) (← links)
- In vivo Electrochemical Biosensor for Brain Glutamate Detection: A Mini Review (Q35518399) (← links)
- Transcriptome outlier analysis implicates schizophrenia susceptibility genes and enriches putatively functional rare genetic variants (Q35882608) (← links)
- Working memory and the homeostatic control of brain adenosine by adenosine kinase (Q36007799) (← links)
- Deletion of adenosine A2A receptors from astrocytes disrupts glutamate homeostasis leading to psychomotor and cognitive impairment: relevance to schizophrenia (Q36468280) (← links)
- Adenosine and autism: a spectrum of opportunities (Q36485460) (← links)
- Adenosinergic signaling in epilepsy (Q36643060) (← links)
- Dysregulation of brain adenosine is detrimental to the expression of conditioned freezing but not general Pavlovian learning (Q36674667) (← links)
- Glial adenosine kinase--a neuropathological marker of the epileptic brain (Q36912637) (← links)
- Dynamic Regulation of the Adenosine Kinase Gene during Early Postnatal Brain Development and Maturation (Q37351896) (← links)
- Heteromeric dopamine receptor signaling complexes: emerging neurobiology and disease relevance (Q37379456) (← links)
- Reduced striatal ecto-nucleotidase activity in schizophrenia patients supports the "adenosine hypothesis". (Q37468669) (← links)
- Are vesicular neurotransmitter transporters potential treatment targets for temporal lobe epilepsy? (Q38134724) (← links)
- Behavioral sequelae of astrocyte dysfunction: focus on animal models of schizophrenia. (Q38281865) (← links)
- The preventive effects of ascorbic acid supplementation on locomotor and acetylcholinesterase activity in an animal model of schizophrenia induced by ketamine (Q38780915) (← links)
- Reviewing the epigenetics of schizophrenia (Q38937402) (← links)
- Progress report on new antiepileptic drugs: A summary of the Thirteenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XIII). (Q39006241) (← links)
- Epigenetic interventions for epileptogenesis: A new frontier for curing epilepsy (Q39171785) (← links)
- South (S)- and North (N)-Methanocarba-7-Deazaadenosine Analogues as Inhibitors of Human Adenosine Kinase. (Q41153115) (← links)
- Paliperidone regulates intracellular redox system in rat brain: Role of purine mechanism. (Q41644149) (← links)
- Adenosine and its receptors as therapeutic targets: An overview (Q42059361) (← links)
- Homeostatic control of synaptic activity by endogenous adenosine is mediated by adenosine kinase. (Q42513030) (← links)
- Quantitative evaluation of the clinical effects of S-adenosylmethionine on mood and behavior in Lesch-Nyhan patients (Q45207077) (← links)
- Targeting ENT1 and adenosine tone for the treatment of Huntington's disease (Q45299960) (← links)
- GSK3β negatively regulates TRAX, a scaffold protein implicated in mental disorders, for NHEJ-mediated DNA repair in neurons. (Q47234216) (← links)
- Pathophysiological Role of Purines and Pyrimidines in Neurodevelopment: Unveiling New Pharmacological Approaches to Congenital Brain Diseases (Q47551317) (← links)
- Targeting the Immune System with Pharmacotherapy in Schizophrenia (Q47837511) (← links)
- A2A-D2 receptor-receptor interaction modulates gliotransmitter release from striatal astrocyte processes (Q48413495) (← links)
- Regional and sex-related differences in modulating effects of female sex steroids on ecto-5'-nucleotidase expression in the rat cerebral cortex and hippocampus (Q48680415) (← links)
- MK-801 alters Na , K -ATPase activity and oxidative status in zebrafish brain: reversal by antipsychotic drugs. (Q48798503) (← links)
- Copy number variant in the region of adenosine kinase (ADK) and its possible contribution to schizophrenia susceptibility (Q50068463) (← links)
- Functional coupling between adenosine A1 receptors and G-proteins in rat and postmortem human brain membranes determined with conventional guanosine-5'-O-(3-[35S]thio)triphosphate ([35S]GTPγS) binding or [35S]GTPγS/immunoprecipitation assay (Q51766518) (← links)
- Sensorimotor gating is disrupted by acute but not chronic systemic exposure to caffeine in mice. (Q52649350) (← links)
- Cell-subtype-specific changes in adenosine pathways in schizophrenia. (Q52684296) (← links)
- The TRAX, DISC1, and GSK3 complex in mental disorders and therapeutic interventions (Q57027971) (← links)
- Alpha-Synuclein Continues to Enhance SNARE-Dependent Vesicle Docking at Exorbitant Concentrations (Q64065382) (← links)
- Alterations of Astrocytes in the Context of Schizophrenic Dementia (Q89964060) (← links)
- Focusing on Adenosine Receptors as a Potential Targeted Therapy in Human Diseases (Q90663193) (← links)
- Potential antipsychotic action of the selective agonist of adenosine A1 receptors, 5'-Cl-5'-deoxy-ENBA, in amphetamine and MK-801 rat models (Q90703914) (← links)
- A therapeutic shock propels Schwann cells to proliferate in peripheral nerve injury (Q91955650) (← links)
- Adenosine kinase inhibition promotes proliferation of neural stem cells after traumatic brain injury (Q93168376) (← links)